Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level.
作者： Jocelin Huang , Ayalew Tefferi
DOI: 10.1111/J.1600-0609.2009.01266.X
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(10)
M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, V Fregoni, G Nalli, G Barosi, E Ascari, Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood. ,vol. 79, pp. 29- 37 ,(1992) , 10.1182/BLOOD.V79.1.29.BLOODJOURNAL79129
Hans Carl Hasselbalch, Nielsaage T�ffner Clausen, Bjarne Anker Jensen, Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin. American Journal of Hematology. ,vol. 70, pp. 92- 99 ,(2002) , 10.1002/AJH.10076
Jocelin Huang, Chin-Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi, Risk factors for leukemic transformation in patients with primary myelofibrosis Cancer. ,vol. 112, pp. 2726- 2732 ,(2008) , 10.1002/CNCR.23505
Ayalew Tefferi, Pharmaceutical Erythropoietin Use in Patients With Cancer: Is It Time to Abandon Ship or Just Drop Anchor? Mayo Clinic Proceedings. ,vol. 82, pp. 1316- 1318 ,(2007) , 10.4065/82.11.1316
Francisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, Ana Sureda, Montserrat Torrebadell, Emili Montserrat, Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature. British Journal of Haematology. ,vol. 127, pp. 399- 403 ,(2004) , 10.1111/J.1365-2141.2004.05229.X
A. Tefferi, M. N. Silverstein, RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA British Journal of Haematology. ,vol. 86, pp. 893- 893 ,(1994) , 10.1111/J.1365-2141.1994.TB04853.X
Wolfgang Jelkmann, Erythropoietin after a century of research: younger than ever. European Journal of Haematology. ,vol. 78, pp. 183- 205 ,(2007) , 10.1111/J.1600-0609.2007.00818.X
Ayalew Tefferi, Jacob J. Strand, Terra L. Lasho, Michelle A. Elliott, Chin-Yang Li, Ruben A. Mesa, Gordon W. Dewald, Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy Cancer. ,vol. 106, pp. 1739- 1743 ,(2006) , 10.1002/CNCR.21787
G. Barosi, L. N. Liberato, R. Guarnone, Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia British Journal of Haematology. ,vol. 83, pp. 365- 369 ,(1993) , 10.1111/J.1365-2141.1993.TB04658.X
S.N. Tsiara, A. Chaidos, L.K. Bourantas, H.D. Kapsali, K.L. Bourantas, Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis. Acta Haematologica. ,vol. 117, pp. 156- 161 ,(2007) , 10.1159/000097463